In contrast, increased BTG2 and LAMP3 expression are accompanied by increased sensitivity of tumor cells to chemotherapeutic agents, such as axitinib, oxaliplatin, and fluorouracil (Figures 9F,G). Here, LAMP3 is linked to neoplasm.